Wall Street analysts expect Healthequity Inc (NASDAQ:HQY) to announce earnings of $0.28 per share for the current fiscal quarter, according to Zacks. Seven analysts have provided estimates for Healthequity’s earnings. The lowest EPS estimate is $0.27 and the highest is $0.29. Healthequity reported earnings per share of $0.27 during the same quarter last year, which would suggest a positive year-over-year growth rate of 3.7%. The company is expected to issue its next earnings results on Tuesday, September 4th.
According to Zacks, analysts expect that Healthequity will report full-year earnings of $1.05 per share for the current financial year, with EPS estimates ranging from $1.02 to $1.07. For the next financial year, analysts expect that the company will post earnings of $1.32 per share, with EPS estimates ranging from $1.22 to $1.43. Zacks Investment Research’s EPS calculations are a mean average based on a survey of research firms that cover Healthequity.
Healthequity (NASDAQ:HQY) last released its earnings results on Monday, June 4th. The company reported $0.31 EPS for the quarter, beating the consensus estimate of $0.22 by $0.09. Healthequity had a net margin of 22.91% and a return on equity of 13.47%. The firm had revenue of $69.90 million for the quarter, compared to analyst estimates of $68.81 million. During the same period last year, the firm earned $0.23 EPS. The business’s quarterly revenue was up 26.2% compared to the same quarter last year.
In other news, insider Stephen Neeleman sold 240,654 shares of the business’s stock in a transaction that occurred on Thursday, May 10th. The shares were sold at an average price of $69.95, for a total value of $16,833,747.30. Following the transaction, the insider now owns 654 shares in the company, valued at approximately $45,747.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Gary D. Robinson sold 1,000 shares of the business’s stock in a transaction that occurred on Tuesday, March 27th. The stock was sold at an average price of $63.02, for a total transaction of $63,020.00. Following the completion of the transaction, the executive vice president now owns 3,369 shares in the company, valued at approximately $212,314.38. The disclosure for this sale can be found here. Insiders sold a total of 480,785 shares of company stock worth $33,194,813 in the last 90 days. Corporate insiders own 4.00% of the company’s stock.
Several hedge funds and other institutional investors have recently modified their holdings of HQY. Citigroup Inc. lifted its position in shares of Healthequity by 414.4% during the 1st quarter. Citigroup Inc. now owns 2,639 shares of the company’s stock valued at $160,000 after acquiring an additional 2,126 shares during the period. M&T Bank Corp acquired a new position in shares of Healthequity during the 1st quarter valued at $206,000. WINTON GROUP Ltd acquired a new position in shares of Healthequity during the 1st quarter valued at $206,000. Two Sigma Securities LLC acquired a new position in shares of Healthequity during the 4th quarter valued at $208,000. Finally, Xact Kapitalforvaltning AB acquired a new position in shares of Healthequity during the 4th quarter valued at $220,000. Hedge funds and other institutional investors own 96.58% of the company’s stock.
Shares of Healthequity opened at $80.63 on Thursday, MarketBeat.com reports. The company has a market cap of $4.99 billion, a P/E ratio of 105.87, a P/E/G ratio of 3.32 and a beta of 1.42. Healthequity has a 1 year low of $40.21 and a 1 year high of $82.04.
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.